Lingenbrink Matthew

FTLF Director Lingenbrink bought 3,000 shares at $9.76; holdings now 8,800 shares; stock -55.4% from 52-week high.

Director Matthew Lingenbrink purchased 3,000 shares at $9.76, increasing his holdings by 51.7% to 8,800 shares. The purchase occurred against a backdrop of sharp recent weakness: the stock is down 55.4% from its 52-week high of $20.76 and has declined 32.9% over the past 30 days and 39.2% over 90 days. Lingenbrink's prior two purchases at FITLIFE BRANDS were both well-timed at the 90-day mark, with gains of 7.0% and 5.2% respectively; his cross-ticker track record shows 100% 90-day win rate across 2 buys. The company's fundamentals show revenue of $23,485,000.00 with net income of $921,000.00 and annual revenue growth of 26.4%, suggesting underlying operational strength despite the equity market deterioration. This combination—sustained insider buying during significant drawdown, consistent prior timing success at this ticker, and solid fundamental growth metrics—is notable, though current price weakness and recent volatility warrant monitoring of near-term momentum.

Director Lingenbrink bought 3,000 shares of FTLF at $12.17, doubling position to 5,800 shares; stock down 32.6% from 52-week high.

Director Matthew Lingenbrink purchased 3,000 shares at $12.17 on 2025-04-14, increasing his holdings from 2,800 to 5,800 shares (+107.1%). The transaction value was $36,510.00. The buy occurred while FITLIFE BRANDS trades $11.80, down 32.6% from its 52-week high of $17.50 and off 13.7% in the prior 30 days. Fundamentals remain solid: the company posted quarterly revenue of $15,977,000.00 with net income of $2,126,000.00 and annual revenue growth of +22.3%, supported by a P/E of 9.01 and market cap of $108,778,630.40. Lingenbrink's prior transaction at this ticker occurred on 2025-03-31 (14 days earlier), indicating active engagement with the position over a compressed timeline.

Director Lingenbrink Matthew bought 2,800 shares of FTLF at $12.17 on 2025-03-31; stock down 29.7% from 52-week high.

Director Lingenbrink Matthew acquired an initial 2,800 shares at $12.17, representing his first shareholding in FITLIFE BRANDS, INC. The purchase occurs in a context of significant stock price weakness: the company trades at $12.30 (current price), down 29.7% from its 52-week high of $17.50 and off 18.5% over the past 30 days. Despite this price deterioration, FTLF maintains reasonable fundamental metrics—a P/E of 9.39, annual revenue growth of +22.3%, and positive quarterly net income of $2.1M on revenues of $16.0M. The entry by a director at a depressed valuation level warrants tracking of whether this represents a single opportunistic purchase or part of a broader accumulation pattern, particularly given the stock's recent momentum headwinds.